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Adult-Onset Myoclonus
Ataxia Associated With the
Mitochondrial m.8993T>C
“NARP” Mutation
Mitochondrial dysfunction is an important cause of neuro-
logical disease. Mitochondrial disease can present at any
age, and the clinical features are extremely varied. The
FIG. 1. Neurophysiological exam of the boy at 3 years of age, performed during a myoclonic attack involving the left upper limb: Polymyographic
recording (A and B) shows profuse continuous positive rhythmic (8-Hz) myoclonus composed of short duration (range, 40-48 ms) repetitive bursts
(arrows), which were synchronous in all the recorded muscles. Negative myoclonus (duration, 270 ms) also occurred intermittently (asterisks), induc-
ing transient loss of tonus. EEG jerk-locked-back-averaging (C) shows a 3-mV transient over the right rolandic central (C4) area preceding myoclonus
by 17.8 ms, which, taken together with polymyography, highly suggests the cortical origin of the myoclonus (averaging of 3 consecutive series of
100 positive jerks). Comparison of T2-weighted MRIs of the patient’s brain at 3 (D) and 7 (E) years of age demonstrates progressive atrophy and
cortical hypersignal of the cerebellar hemispheres. A1-A2, ear-linked reference; ECR, extensor carpi radialis; FCR, flexor carpi radialis; Acc,
accelerometer.
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mitochondrial DNA (mtDNA) m.8993T>C mutation is usu-
ally encountered either in association with Leigh syndrome1
or the syndrome of neuropathy, ataxia, and retinitis pigmen-
tosa (NARP).2 We describe severe, late-onset myoclonus
ataxia related to the m.8993T>C mutation.
A 74-year-old man presented with a 3-year history of progres-
sive hand clumsiness and poor balance. He was now wheelchair-
bound and needed assistance in dressing, feeding, and washing.
There was no history of seizures. He had a sister with diabetes
mellitus and coeliac disease, but otherwise well. Family history
was unremarkable for movement disorders and other neurologi-
cal conditions. Both the patient and his sister had no children,
and their mother who was deceased was an only child.
Clinical examination revealed bilateral, irregular, and mul-
tifocal myoclonus in both upper limbs, considerably aggra-
vated by active movement. No pigmentary retinopathy was
detected. Up-gaze was limited, but with intact smooth pur-
suit. Cognition was normal. Proximal (MRC 4/5) and distal
(MRC 41/5) muscle weakness was evident. Lower-limb
reflexes were absent. Severe myoclonus ataxia rendered him
unable to walk or stand independently.
Urea, liver function tests, creatinine kinase, serum lactate,
vitamin E, blood copper, and coeruloplasmin levels were
unremarkable. Testing for anti-gliadin and anti-endomysial
antibodies was negative.
Brain MRI revealed global cortical and cerebellar atrophy.
Nerve conduction studies revealed a predominantly sensory
axonal neuropathy. EEG did not reveal any epileptiform fea-
tures. Photic stimulation evoked further myoclonic jerks
associated with muscle activity artefact.
Fragile X–associated tremor ataxia syndrome and spinocere-
bellar ataxia types 1 to 3, 6, 7, and 17 were excluded; SGCE
gene analysis was normal. Given that clinical features were
suggestive of a mitochondrial disorder rather than other
causes of myoclonus ataxia, common POLG mutations
(p.Ala467Thr, p.Trp748Ser, and p.Gly848Ser) and mtDNA
point mutations associated with MERRF (myoclonic epilepsy
with ragged-red fibers) syndrome (m.8344A>G, m.8356T>C,
and m.8363G>A) were excluded. Pyrosequencing of the
MTATP6 and MTATP8 genes (methodology as described by
Alston et al.3) revealed the m.8993T>C mutation in MTATP6
at 95% heteroplasmy in the patient’s blood and urine. The
m.8993T>C mutation was undetectable in the respective sam-
ples from his sister, suggesting a sporadic mutation, although
a maternal sample was not available to confirm this.
Myoclonus linked with ataxia is a common feature of the
m.8344A>G MERRF mutation,4 and it has been reported with
POLG mutations.5 Adult-onset ataxia and axonal neuropathy
owing to the m.8993T>C mutation has been reported in a Fin-
nish family,2 but severe myoclonus ataxia in association with
the m.8993T>C mutation has not been previously reported.
The patient’s late symptom onset is remarkable. Clinical clues
suggesting a possible late-onset mitochondrial disorder were
the multisystem nature of the disorder and a phenotype charac-
terized by myoclonus ataxia, neuropathy, and the mild up-gaze
limitation. Cerebellar pathology and ataxia are common fea-
tures of mitochondrial disease. Recently, the cerebellum has
been implicated in the pathogenesis of cortical myoclonus.6
Apart from mitochondrial disease, myoclonus ataxia can be
associated with many other conditions, such as coeliac disease,
and various rare metabolic or genetic disorders.7 Mitochondrial
disease related to the m.8993T>C mutation should be consid-
ered among adult patients who present with nondominant myo-
clonus ataxia, irrespective of age.
Legends to the Videos
Video 1. This video was taken at the age of 73 years. The
sensitivity of the myoclonic jerks to photic stimulation is
demonstrated during the EEG recording.
Video 2. This video was taken at the age of 74 years. The
severe myoclonus ataxia is demonstrated during the finger-to-
finger test and when trying to pick up a pen. On examination of
the eye movements, smooth pursuit is intact, but there is evidence
of marked upward gaze restriction. The head drop is owing to
neck extensor weakness (MRC 4/5) rather than dystonia.
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